Cargando…
mRNA Vaccines: The Dawn of a New Era of Cancer Immunotherapy
mRNA therapy is a novel anticancer strategy based on in vitro transcription (IVT), which has potential for the treatment of malignant tumors. The outbreak of the COVID-19 pandemic in the early 21st century has promoted the application of mRNA technologies in SARS-CoV-2 vaccines, and there has been a...
Autores principales: | Deng, Zhuoya, Tian, Yuying, Song, Jianxun, An, Guangwen, Yang, Penghui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201022/ https://www.ncbi.nlm.nih.gov/pubmed/35720301 http://dx.doi.org/10.3389/fimmu.2022.887125 |
Ejemplares similares
-
mRNA vaccines: A novel weapon to control infectious diseases
por: Tian, Yuying, et al.
Publicado: (2022) -
Neoantigen Targeting—Dawn of a New Era in Cancer Immunotherapy?
por: Wirth, Thomas C., et al.
Publicado: (2017) -
An OX40L mRNA vaccine inhibits the growth of hepatocellular carcinoma
por: Deng, Zhuoya, et al.
Publicado: (2022) -
mRNA vaccines for cancer immunotherapy
por: Vishweshwaraiah, Yashavantha L., et al.
Publicado: (2022) -
Potentialities and Challenges of mRNA Vaccine in Cancer Immunotherapy
por: Duan, Li-Juan, et al.
Publicado: (2022)